Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Melanoma 86Carcinoma, Renal Cell 29Lymphoma 26Kidney Neoplasms 26Leukemia 25Leukemia, Myeloid, Acute 24Lymphoma, Follicular 16Lymphoma, Non-Hodgkin 15Lymphoma, Mantle-Cell 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia, Lymphocytic, Chronic, B-Cell 13Breast Neoplasms 12Neoplasm Metastasis 11Lymphoma, Large B-Cell, Diffuse 10Lymphoma, B-Cell, Marginal Zone 10Skin Neoplasms 9Myelodysplastic Syndromes 9Lymphoma, Large-Cell, Immunoblastic 9Hodgkin Disease 9Burkitt Lymphoma 9Neuroblastoma 8Congenital Abnormalities 8Recurrence 7Ovarian Neoplasms 7Multiple Myeloma 7Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 6Leukemia, Myelomonocytic, Chronic 6Gliosarcoma 6Glioblastoma 6

Interventions

Cyclophosphamide 20Trastuzumab 12Epirubicin 12Doxorubicin 12Docetaxel 11Paclitaxel 10Filgrastim 8Carboplatin 7Radiotherapy 6Bevacizumab 5Neoadjuvant Therapy 4Lapatinib 4Granulocyte Colony-Stimulating Factor 4Albumin-Bound Paclitaxel 4tipifarnib 3pertuzumab 3pegfilgrastim 3Thiotepa 3Taxes 3Tamoxifen 3Surgical Procedures, Operative 3Melphalan 3Fluorouracil 3Chemotherapy, Adjuvant 3Capecitabine 3130-nm albumin-bound paclitaxel 3Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Flow Cytometry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Inflammatory Breast Neoplasms × aldesleukin × Clear all
NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Fred Hutchinson Cancer Center

Phase 2 Completed
50 enrolled 11 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡